The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region

  • Sakata T
  • Brunisholz K
  • Andersen C
  • et al.
7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Monoclonal antibody (MAb) treatments have been safe and effective in averting severe Covid-19 infections when given early, but supplies have been scarce. Intermountain Healthcare used its supply to...

References Powered by Scopus

SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19

1006Citations
N/AReaders
Get full text

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients with Early COVID-19

38Citations
N/AReaders
Get full text

Rapid Implementation of a Complex, Multimodal Technology Response to COVID-19 at an Integrated Community-Based Health Care System

15Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021

105Citations
N/AReaders
Get full text

The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19

5Citations
N/AReaders
Get full text

Social Determinants of Health and COVID-19

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sakata, T., Brunisholz, K. D., Andersen, C., Davie, D., Srivastava, R., & Webb, B. J. (2021). The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region. NEJM Catalyst, 2(9). https://doi.org/10.1056/cat.21.0154

Readers' Seniority

Tooltip

Lecturer / Post doc 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

50%

Pharmacology, Toxicology and Pharmaceut... 1

50%

Save time finding and organizing research with Mendeley

Sign up for free